» Articles » PMID: 35600942

Insulin Aspart Combined with Exercise Therapy in Spleen Deficiency Type Gestational Diabetes Mellitus: The Effect on Disease Control and Pregnancy Outcomes

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To investigate the effect of insulin aspart combined with exercise therapy on the disease control and pregnancy outcomes of spleen deficiency type gestational diabetes mellitus patients.

Methods: In this prospective study, a total of 102 patients with spleen deficiency type gestational diabetes mellitus admitted to our hospital from January 2019 to December 2019 were selected and assigned at a ratio of 1 : 1 via the random number table method to receive insulin aspart (control group) or insulin aspart plus exercise therapy (observation group). Outcome measures include blood sugar, clinical efficacy, adverse pregnancy outcomes, and complications.

Results: Insulin aspart plus exercise therapy was associated with significantly lower blood glucose and glycosylated hemoglobin levels versus insulin aspart alone ( < 0.05). Insulin aspart plus exercise therapy resulted in significantly higher total efficacy (96.08%) versus insulin aspart (74.51%) ( < 0.05). Patients receiving insulin aspart plus exercise therapy showed a significantly lower incidence of adverse pregnancy outcomes (3.92%) versus those given insulin aspart alone (37.25%) ( < 0.05). Insulin aspart plus exercise therapy resulted in a lower incidence of complications (5.88%) versus insulin aspart (41.17%) ( < 0.05).

Conclusion: Exercise therapy plus insulin aspart might offer a viable treatment alternative for patients with spleen deficiency-type gestational diabetes mellitus given its promising effects in disease control and pregnancy outcomes, with good efficacy and safety profiles.

Citing Articles

Retracted: Insulin Aspart Combined with Exercise Therapy in Spleen Deficiency Type Gestational Diabetes Mellitus: The Effect on Disease Control and Pregnancy Outcomes.

And Alternative Medicine E Evid Based Complement Alternat Med. 2023; 2023:9862892.

PMID: 37476345 PMC: 10356246. DOI: 10.1155/2023/9862892.

References
1.
Kintiraki E, Goulis D . Gestational diabetes mellitus: Multi-disciplinary treatment approaches. Metabolism. 2018; 86:91-101. DOI: 10.1016/j.metabol.2018.03.025. View

2.
Wang W, Fan Y, Lin Q . Metformin combined with insulin aspart for ameliorating blood glucose levels and maternal and neonatal outcomes in women with gestational diabetes mellitus and chronic hypertension. Am J Transl Res. 2021; 13(5):5596-5602. PMC: 8205779. View

3.
Zhu W, Shen Y, Liu J, Fei X, Zhang Z, Li M . Epigenetic alternations of microRNAs and DNA methylation contribute to gestational diabetes mellitus. J Cell Mol Med. 2020; 24(23):13899-13912. PMC: 7753873. DOI: 10.1111/jcmm.15984. View

4.
Laredo-Aguilera J, Gallardo-Bravo M, Rabanales-Sotos J, Cobo-Cuenca A, Carmona-Torres J . Physical Activity Programs during Pregnancy Are Effective for the Control of Gestational Diabetes Mellitus. Int J Environ Res Public Health. 2020; 17(17). PMC: 7503359. DOI: 10.3390/ijerph17176151. View

5.
Rasmussen L, Poulsen C, Kampmann U, Smedegaard S, Ovesen P, Fuglsang J . Diet and Healthy Lifestyle in the Management of Gestational Diabetes Mellitus. Nutrients. 2020; 12(10). PMC: 7599681. DOI: 10.3390/nu12103050. View